Mut. Pharm. Co. v. Bartlett, 568 U.S. 1045 (2012). · Go Syfert
Search
Mut. Pharm. Co. v. Bartlett, 568 U.S. 1045 (2012). Cases Citing This Book View Copy Cite
12 citation events (12 in the last 25 years) across 9 distinct courts.
Strongest positive: Genetic Technologies Ltd. v. Bristol-Myers Squibb Co. (ded, 2014-10-30)
Top citers, strongest first. 2 distinct citers. How cited ↗
discussed Cited "see" Genetic Technologies Ltd. v. Bristol-Myers Squibb Co.
D. Del. · 2014 · signal: see · confidence high
See AMP, 689 F.3d at 1334 , cert. granted in part, — U.S. —, 133 S.Ct. 694 , 184 L.Ed.2d 496 (2012), aff'd in part, rev’d in part , — U.S. —, 133 S.Ct. 2107 , 186 L.Ed.2d 124 (reversing eligibility ruling for isolated DNA composition claims).
cited Cited "see" Association for Molecular Pathology v. Myriad Genetics, Inc.
SCOTUS · 2013 · signal: see · confidence high
See Association for Molecular Pathology v. Myriad Genetics, Inc., 566 U.S. ----, 133 S.Ct. 694 , 184 L.Ed.2d 496 (2012).
Retrieving the full opinion text from the archive…
Mutual Pharmaceutical Co., Inc.
v.
Bartlett
No. 12-142.
Supreme Court of the United States.
Nov 30, 2012.
568 U.S. 1045
Cited by 1 opinion  |  Published

C. A. 1st Cir. Certiorari granted.